Journal Information
Original article
Full text access
Safety of immunotherapy in patients with rhinitis, asthma or atopic dermatitis using an ultra-rush buildup. A retrospective study
a Group of Clinical and Experimental Allergy (GACE) University of Antioquia, Medellin, Colombia
b Clinical Allergology Service University of Antioquia, Medellin, Colombia
c Foundation for the Development of Medical and Biological Sciences (FUNDEMEB), Cartagena, Colombia
d Institute for Immunological Research (III) University of Cartagena, Cartagena, Colombia
Article
This article is available in English
Safety of immunotherapy in patients with rhinitis, asthma or atopic dermatitis using an ultra-rush buildup. A retrospective study
R. Cardona, E. Lopez, J. Beltrán, J. Sánchez
10.1016/j.aller.2012.07.005Allergol Immunopathol (Madr). 2014;42:90-5